Atlas Venture logo

Atlas Venture

Crunchbase
Crunchbase

Deals on record

12

Common Fundraising Type

Series A

Be Bio logo
Be Bio

Engineered B Cell Medicines

Nextech logo
Takeda Ventures logo
RA Capital Management logo
Longwood Fund logo
Bristol Myers Squibb logo
Atlas Venture logo
Arch Venture Partners logo
Alta Partners logo

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Series C
$92M
01/15/2025
Article
nChroma Bio logo
nChroma Bio

Epigenetic editing

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo
Sixth Street logo
Omega Funds logo
Mubadala Capital logo
Menlo Ventures logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
Trace Neuroscience logo
Trace Neuroscience

Genomic therapies

Third Rock Ventures logo
GV logo
RA Capital Management logo
Atlas Venture logo

Trace Neuroscience is a biopharmaceutical company developing genomic therapies for neurodegenerative diseases, with a focus on treating amyotrophic lateral sclerosis (ALS) by restoring the UNC13A protein.

Series A
$101M
11/12/2024
Article
Be Bio logo
Be Bio

Engineered B Cell Medicines

Takeda Ventures logo
RA Capital Management logo
Longwood Fund logo
Bristol Myers Squibb logo
Atlas Venture logo
Arch Venture Partners logo
Alta Partners logo

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Equity
$82M
10/22/2024
Article
Kailera Therapeutics logo
Kailera Therapeutics

Biopharmaceutical

RTW Investments logo
Lyra Capital logo
Bain Capital Life Sciences logo
Atlas Venture logo

Kailera Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and related metabolic conditions.

Series A
$400M
10/07/2024
Article

Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.

Series B
$115M
10/02/2024
Article
DC Connected logo
DC Connected

AI-driven

Venpace logo
Borusan Ventures logo
Bloomhaus Ventures logo
Atlas Ventures logo
APX logo

DC Connected is an AI-driven vehicle diagnostics platform that provides real-time problem-solution recommendations for multi-brand vehicles.

Seed
$2.3M
09/12/2024
Article

Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.

Series A
$92M
10/26/2023
Article
Aiolos Bio logo
Aiolos Bio

Biopharmaceutical

Sofinnova Investments logo
RA Capital Management logo
Forbion logo
Bain Capital Life Sciences logo
Atlas Venture logo

Aiolos Bio is a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, with a lead drug candidate, AIO-001, that is a potentially best-in-class TSLP antibody dosed every 6 months.

Series A
$245M
10/24/2023
Article
Ai Build logo
Ai Build

Additive manufacturing

Superseed logo
Seedcamp logo
Nikon logo
IQ Capital logo
Atlas Ventures logo
ACT Venture Partners logo

Ai Build is a London-based additive manufacturing software company that automates the additive manufacturing process, improving speed, quality, scalability, and application range across the entire enterprise.

Series A
$8.5M
10/19/2023
Article
Mariana Oncology logo
Mariana Oncology

Biotechnology

Forbion logo
Deep Track Capital logo
Surveyor Capital logo
RA Capital Management logo
Nextech Invest logo
Eli Lilly and Company logo
Atlas Venture logo
Access Biotechnology logo

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.

Series B
$175M
09/07/2023
Article
Nimbus Therapeutics logo
Nimbus Therapeutics

Computational Drug Discovery

SR One logo
GV logo
Atlas Venture logo
SV Health Investors logo
RA Capital Management logo
Pfizer Ventures logo
Bain Capital Life Sciences logo
BVF Partners logo

Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.

Equity
$210M
09/06/2023
Article